Genome-wide Significance for a Modifier of Age at Neurological Onset in Huntington's Disease at 6q23-24: The HD MAPS Study
View/ Open
Author
Li, Jian-Liang
Hayden, Michael R
Warby, Simon C
Durr, Alexandra
Morrison, Patrick J
Nance, Martha
Ross, Christopher A
Margolis, Russell L
Rosenblatt, Adam
Squitieri, Ferdinando
Frati, Luigi
Gómez-Tortosa, Estrella
García, Carmen Ayuso
Suchowersky, Oksana
Klimek, Mary Lou
Trent, Ronald JA
McCusker, Elizabeth
Novelletto, Andrea
Frontali, Marina
Paulsen, Jane S
Jones, Randi
Ashizawa, Tetsuo
Lazzarini, Alice
Prakash, Ranjana
Djoussé, Luc
Mysore, Jayalakshmi Srinidhi
Gillis, Tammy
Hakky, Michael
Cupples, L Adrienne
Saint-Hilaire, Marie H
Penney, John B
Harrison, Madaline B
Perlman, Susan L
Zanko, Andrea
Abramson, Ruth K
Lechich, Anthony J
Duckett, Ayana
Marder, Karen
Conneally, P Michael
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/1471-2350-7-71Metadata
Show full item recordCitation
Li, Jian-Liang, Michael R Hayden, Simon C Warby, Alexandra Durr, Patrick J Morrison, Martha Nance, Christopher A Ross, and et al. 2006. Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study. BMC Medical Genetics 7: 71.Abstract
Background: Age at onset of Huntington's disease (HD) is correlated with the size of the abnormal CAG repeat expansion in the HD gene; however, several studies have indicated that other genetic factors also contribute to the variability in HD age at onset. To identify modifier genes, we recently reported a whole-genome scan in a sample of 629 affected sibling pairs from 295 pedigrees, in which six genomic regions provided suggestive evidence for quantitative trait loci (QTL), modifying age at onset in HD. Methods: In order to test the replication of this finding, eighteen microsatellite markers, three from each of the six genomic regions, were genotyped in 102 newly recruited sibling pairs from 69 pedigrees, and data were analyzed, using a multipoint linkage variance component method, in the follow-up sample and the combined sample of 352 pedigrees with 753 sibling pairs. Results: Suggestive evidence for linkage at 6q23-24 in the follow-up sample (LOD = 1.87, p = 0.002) increased to genome-wide significance for linkage in the combined sample (LOD = 4.05, p = 0.00001), while suggestive evidence for linkage was observed at 18q22, in both the follow-up sample (LOD = 0.79, p = 0.03) and the combined sample (LOD = 1.78, p = 0.002). Epistatic analysis indicated that there is no interaction between 6q23-24 and other loci. Conclusion: In this replication study, linkage for modifier of age at onset in HD was confirmed at 6q23-24. Evidence for linkage was also found at 18q22. The demonstration of statistically significant linkage to a potential modifier locus opens the path to location cloning of a gene capable of altering HD pathogenesis, which could provide a validated target for therapeutic development in the human patient.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586197/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:5141361
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)